Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Antidepressant Therapy in Bipolar II Major Depression
NCT00641927Phase 4Completed
- Sponsor
- Stanley Medical Research Institute
- Start
- Apr 2002
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of venlafaxine in Bipolar II disorder (BP-II) (2 arms), sponsored by Stanley Medical Research Institute. Primary endpoint: Hamilton Depression Rating Scale at 12 weeks. Started Apr 2002; status: completed.
02
Drugs
venlafaxine
03
Conditions
Bipolar II disorder (BP-II)
Beyond the preview
Go deeper on NCT00641927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00641927.